Monday, June 8
Professional Development Workshop
8:00 a.m. – 6:30 p.m.
NCI Shady Grove Campus
9609 Medical Center Drive
Rockville, MD 20850

Tuesday, June 9
Professional Development Workshop
8:00 a.m. – 11:00 a.m.
Johns Hopkins University
9601 Medical Center Drive
Rockville, MD 20850

Mock Review
11:00 a.m. – 4:00 p.m.
Johns Hopkins University
9601 Medical Center Drive
Rockville, MD 20850


Call for Posters

Poster Session at the CRCHD 2015 Professional Development Workshop

The poster session aims to enhance mutually beneficial interactions among CRCHD New and Early Stage Investigators* from across all research categories.

Session objectives include:

  • Highlighting scientific achievements across CRCHD Career Development Grantees.
  • Enhancing networking opportunities among peers and established investigators representing cancer and cancer health disparities programs.

The poster competition is scheduled for Monday, June 8, from 12:00 PM to 2:00 PM and 5:00 PM to 6:30 PM.

For each abstract submitted, please carefully read and follow the Abstract Submission and Poster Guidelines (below).

All poster abstracts must be received by May 15, 2015.

Abstract Submission Guidelines

Abstracts must be submitted online at http://www.cancermeetings.org/PDW2015/abstract-upload.cfm using minimal text formatting (i.e., tables, etc.). Submissions should highlight novel scientific, clinical, and training efforts; applications in the community; and policy implications of various approaches across the cancer control continuum among diverse populations.

Submitted abstracts should not exceed 250 words and must include:

  1. Title of abstract
  2. Author name(s), affiliation(s)
  3. Primary presenter, affiliation, address, phone number and email
  4. Target population and cancer site
  5. Background, objectives, methods, results, implications, conclusions, and next steps

Research Categories for Abstracts

On the abstract submission form, please indicate the appropriate category.

Basic and Translational Research
  • Cancer cell biology
  • Cancer etiology
  • Cancer immunology and hematology
  • DNA and chromosome aberrations
  • Structural biology
  • Tumor microenvironment
  • Emerging technologies
  • Genetics
  • Epigenetics

Behavioral or Community-Based Participatory Research Methods, Data, and Evaluation (Behavioral or CBPR)
  • Identification and prevention of risk factors
  • Social, cultural, and environmental influences on behavioral change (individual, community, or organizational level)
  • Effective and efficacious intervention development
  • Community partnerships and adoption
  • Survivorship issues
  • Innovative outreach strategies
  • Program sustainability

Clinical Research Addressing Systemic Cancer Care Barriers (Clinical)
  • Patient accrual challenges
  • Undocumented treatment
  • Patient care barriers (e.g., financial, literacy, reimbursement, transportation)
  • Un-/underinsured
  • Continuum of care
  • Cultural competency

Abstract Selection Criteria

Abstracts will be selected by peer review based on relevance to the research quality, innovation, methodology, results, and contribution to knowledge. Submissions related to common topics will be grouped together for presentation depending on the chosen format. If your abstract is selected, you will receive a notice by May 29, 2015, including presentation guidelines.

Submissions must be received by May 15, 2015.

Poster Submission Guidelines

Posters will be displayed on 4' high x 6' wide poster board and will compete with posters in the appropriate research category. The categories are as described above: basic research; behavioral research or CBPR; and clinical research. A poster board and push pins will be provided.

Poster setup and breakdown hours will be available shortly via the Program Meeting web site.

Posters will be judged on the basis of scientific content; clarity of the presentation of the material on the poster; the individual presentation and response to questions from judges; innovation; and thoroughness.

Prizes will be awarded to 1st, 2nd, and 3rd place winners within each category.

*Please Note

A New Investigator is an NIH research grant applicant who has not yet been awarded a substantial competing NIH research grant. An individual who has received a small grant (R03) or an Exploratory Developmental Research Grant Award (R21) is considered a New Investigator.

An Early Stage Investigator is an individual who has completed his or her terminal research degree or medical residency—whichever date is later—within the past 10 years and has not yet been awarded a substantial competing NIH research grant.

 


Go to www.cancer.gov Go to www.nih.gov Go to www.cancer.gov Go to homepage